Faecal calprotectin - the Crohn's disease activity predictor of the future.
作者信息
Ramphul Priyanka
机构信息
Royal Stoke University Hospital, Staffordshire, UK.
出版信息
Clin Med (Lond). 2016 Jun 1;16 Suppl 3(Suppl 3):s28. doi: 10.7861/clinmedicine.16-3-s28.
Abstract
摘要
相似文献
1
Faecal calprotectin - the Crohn's disease activity predictor of the future.
Clin Med (Lond). 2016 Jun 1;16 Suppl 3(Suppl 3):s28. doi: 10.7861/clinmedicine.16-3-s28.
2
Faecal calprotectin but not C-reactive protein (CRP) or Crohn's Disease Activity Index (CDAI) may predict post-operative endoscopic recurrence of Crohn's disease.
J Crohns Colitis. 2013 Dec;7(12):e700-1. doi: 10.1016/j.crohns.2013.07.008. Epub 2013 Aug 13.
3
Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin.
Rev Esp Enferm Dig. 2017 Feb;109(2):130-136. doi: 10.17235/reed.2017.4542/2016.
4
Can fecal calprotection identify postoperative recurrence of Crohn's disease?
Inflamm Bowel Dis. 2015 May;21(5):E7. doi: 10.1097/MIB.0000000000000390.
5
Reply to can fecal calprotection identify postoperative recurrence of Crohn's disease?
Inflamm Bowel Dis. 2015 May;21(5):E7. doi: 10.1097/MIB.0000000000000416.
6
Evaluation of Crohn's disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin.
Eur Radiol. 2014 Feb;24(2):277-87. doi: 10.1007/s00330-013-3010-z. Epub 2013 Sep 12.
7
Faecal calprotectin: a bright future for assessing disease activity in Crohn's disease.
QJM. 2002 Sep;95(9):557-8. doi: 10.1093/qjmed/95.9.557.
8
Chronic cheilitis: Faecal calprotectin test a way to diagnose oral Crohn's disease.
Australas J Dermatol. 2017 Nov;58(4):324-325. doi: 10.1111/ajd.12598. Epub 2017 Jul 21.
9
Fecal Calprotectin Profiles in Crohn's Disease: A Longitudinal Data Analysis.
Clin Gastroenterol Hepatol. 2024 Aug;22(8):1750-1751. doi: 10.1016/j.cgh.2023.11.015. Epub 2023 Nov 28.
10
Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease.
Dig Liver Dis. 2018 Apr;50(4):353-359. doi: 10.1016/j.dld.2017.12.022. Epub 2017 Dec 30.
引用本文的文献
1
Local Guidelines Regarding the Therapeutic and Diagnostic Management of Silent Crohn's Patients.
Int J Prev Med. 2025 Jul 30;16:45. doi: 10.4103/ijpvm.ijpvm_13_24. eCollection 2025.
本文引用的文献
1
Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
Frontline Gastroenterol. 2015 Jan;6(1):14-19. doi: 10.1136/flgastro-2013-100420. Epub 2014 Mar 17.
2
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease.
Gastroenterology. 2000 Jul;119(1):15-22. doi: 10.1053/gast.2000.8523.
Zotero 插件